Traditional MedicareCoverageMedium impact
Ophthalmic Angiography (Fluorescein and Indocyanine Green)
Medicare/CMS - LCD·Ophthalmology·Local Coverage Determination
Effective date
May 28, 2026
We identified it
Jun 17, 2026
Summary
This is a Local Coverage Determination for Ophthalmic Angiography procedures including fluorescein and indocyanine green angiography, managed by CGS Administrators LLC for Medicare Part A and Part B. The policy will be effective May 28, 2026, but the specific coverage changes or requirements are not detailed in the provided policy content.
Action Required
By May 28, 2026: Billing team must review the complete LCD L34175 policy text at the CMS Medicare Coverage Database to understand specific coverage criteria, documentation requirements, and billing guidelines for ophthalmic angiography procedures. Update billing protocols and provider documentation requirements accordingly.